JP Morgan added Dollar Tree (NASDAQ:DLTR) to its Analyst Focus List as a growth idea and reiterated its Overweight rating, ...

Sarepta Therapeutics came under pressure after two brokerages slashed their price targets and downgraded the stock, flagging mounting safety, regulatory, and credibility concerns around its gene ...